NanoViricides, Inc.
NNVC
$1.26
$0.010.80%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.04M | 3.75M | 3.08M | 2.63M | 2.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.53M | 9.65M | 8.52M | 9.80M | 9.70M |
| Operating Income | -9.53M | -9.65M | -8.52M | -9.80M | -9.70M |
| Income Before Tax | -9.36M | -9.45M | -8.29M | -9.51M | -9.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.36 | -9.45 | -8.29 | -9.51 | -9.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.36M | -9.45M | -8.29M | -9.51M | -9.36M |
| EBIT | -9.53M | -9.65M | -8.52M | -9.80M | -9.70M |
| EBITDA | -8.75M | -8.89M | -7.76M | -9.04M | -8.95M |
| EPS Basic | -0.72 | -0.76 | -0.70 | -0.81 | -0.80 |
| Normalized Basic EPS | -0.45 | -0.47 | -0.44 | -0.51 | -0.50 |
| EPS Diluted | -0.72 | -0.76 | -0.70 | -0.81 | -0.80 |
| Normalized Diluted EPS | -0.45 | -0.47 | -0.44 | -0.51 | -0.50 |
| Average Basic Shares Outstanding | 52.31M | 49.48M | 47.48M | 46.91M | 46.77M |
| Average Diluted Shares Outstanding | 52.31M | 49.48M | 47.48M | 46.91M | 46.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |